Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 184Recruiting 63Active not recruiting 61Unknown 53Terminated 50Withdrawn 11Not yet recruiting 11Enrolling by invitation 2Suspended 1No longer available 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2Neoplasms 1

Interventions

Surgical Procedures, Operative 2Music Therapy 2Letrozole 2Fluorodeoxyglucose F18 2Drug Therapy 2sacituzumab govitecan 1ribociclib 1pembrolizumab 1exemestane 1dalpiciclib 1Zoledronic Acid 1Vitamin D 1Transurethral Resection of Bladder 1Therapeutics 1Tamoxifen 1Synbiotics 1Self-Help Groups 1Resistance Training 1Relaxation Therapy 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Radiation 1Prebiotics 1Oxygen Inhalation Therapy 1Neoadjuvant Therapy 1Mastectomy, Segmental 1Mastectomy, Modified Radical 1Mastectomy 1Mannitol 1Mammography 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Enrolling by invitation × Letrozole × Breast × Clear all
NCT06650748 2026-03-17

NeoMARS

Peking University

Phase 2 Enrolling by invitation
100 enrolled
Breast

Breast Neoplasms

NCT05645536 2026-01-12

Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA Study

Tolmar Inc.

Phase 3 Enrolling by invitation
250 enrolled
Breast

Breast Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡